Nifty Pharma Index
NIFTY PHARMANifty Pharma Index
NIFTY PHARMA
Price Chart
Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.32 | 5.78 | 0.62% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.72% | 20 | — |
About Index
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return1.48% | 1.48% | 1.48% | 100.00% | Free float Mcap783.71 Weight100.00% | |
Abbott India LtdABBOTINDIA 0.71% Return attribution0.01% | 0.71% | 0.01% | 2.01% | 15.73 Weight2.01% | |
Alkem Laboratories LtdALKEM 2.85% Return attribution0.08% | 2.85% | 0.08% | 2.86% | 22.43 Weight2.86% | |
Aurobindo Pharma LtdAUROPHARMA 0.40% Return attribution0.02% | 0.40% | 0.02% | 5.53% | 43.30 Weight5.53% | |
Biocon LtdBIOCON 1.03% Return attribution0.02% | 1.03% | 0.02% | 2.05% | 16.05 Weight2.05% | |
Zydus Lifesciences LtdZYDUSLIFE 0.37% Return attribution-0.01% | 0.37% | -0.01% | 3.60% | 28.22 Weight3.60% | |
Cipla LtdCIPLA 2.25% Return attribution0.26% | 2.25% | 0.26% | 11.45% | 89.76 Weight11.45% | |
Dr Reddy's Laboratories LtdDRREDDY 1.45% Return attribution0.15% | 1.45% | 0.15% | 10.58% | 82.93 Weight10.58% | |
Divi's Laboratories LtdDIVISLAB 1.62% Return attribution0.13% | 1.62% | 0.13% | 8.24% | 64.61 Weight8.24% | |
Glenmark Pharmaceuticals LtdGLENMARK 2.39% Return attribution0.07% | 2.39% | 0.07% | 3.06% | 23.96 Weight3.06% | |
Granules India LtdGRANULES 2.02% Return attribution0.03% | 2.02% | 0.03% | 1.25% | 9.81 Weight1.25% | |
IPCA Laboratories LtdIPCALAB 1.25% Return attribution0.03% | 1.25% | 0.03% | 2.35% | 18.40 Weight2.35% | |
J B Chemicals and Pharmaceuticals LtdJBCHEPHARM 0.37% Return attribution-0.01% | 0.37% | -0.01% | 1.78% | 13.91 Weight1.78% | |
Laurus Labs LtdLAURUSLABS 2.70% Return attribution0.06% | 2.70% | 0.06% | 2.14% | 16.74 Weight2.14% | |
Lupin LtdLUPIN 2.12% Return attribution0.15% | 2.12% | 0.15% | 6.89% | 54.00 Weight6.89% | |
Natco Pharma LtdNATCOPHARM 2.56% Return attribution0.04% | 2.56% | 0.04% | 1.71% | 13.39 Weight1.71% | |
Sanofi India LtdSANOFI 0.56% Return attribution0.00% | 0.56% | 0.00% | 0.79% | 6.18 Weight0.79% | |
Sun Pharmaceutical Industries LtdSUNPHARMA 1.25% Return attribution0.31% | 1.25% | 0.31% | 24.70% | 193.61 Weight24.70% | |
Torrent Pharmaceuticals LtdTORNTPHARM 1.47% Return attribution0.06% | 1.47% | 0.06% | 4.31% | 33.78 Weight4.31% | |
Gland Pharma LtdGLAND 0.57% Return attribution-0.01% | 0.57% | -0.01% | 1.72% | 13.45 Weight1.72% | |
Mankind Pharma LtdMANKIND 2.55% Return attribution0.08% | 2.55% | 0.08% | 2.99% | 23.43 Weight2.99% |
ETFs tracking this Index
There are no ETFs tracking this index. Events
Dividends
Corp. Actions
Announcements
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash DividendNATCOPHARM
NATCOPHARMEx DateEx DateAug 23, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Aug 23, 2024
Cash DividendGLAND
GLANDEx DateEx DateAug 16, 2024
Dividend/Share
₹20.00
Ex DateEx Date
Aug 16, 2024
Cash DividendJBCHEPHARM
JBCHEPHARMEx DateEx DateAug 14, 2024
Dividend/Share
₹6.75
Ex DateEx Date
Aug 14, 2024
Cash DividendALKEM
ALKEMEx DateEx DateAug 9, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Aug 9, 2024
Cash DividendIPCALAB
IPCALABEx DateEx DateAug 6, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Aug 6, 2024
News & Opinions
Alkem Laboratories Ltd spurts 2.93%, up for fifth straight session
1 day ago•Business Standard
Natco Pharma shares jump 5% as company files for generic cancer drug approval with USFDA
1 day ago•Economic Times
Sensex gains 204 pts; Pharma shares in demand
1 day ago•Business Standard
India’s pharma sector set for 9.6% CAGR, reaching $55 bn by 2030: Report
2 days ago•Business Standard
Indian pharmaceutical industry expected to reach $55 billion by 2030: Report
2 days ago•Business Today
Stock market update: Nifty Pharma index falls 0.48%
2 days ago•Economic Times
Pharma Sector Q1 Results Review - Select Bets To Continue To Perform: DRChoksey
2 days ago•Bloomberg Quint
